Cargando…
Developments in targeted therapy & immunotherapy—how non-small cell lung cancer management will change in the next decade: a narrative review
BACKGROUND AND OBJECTIVE: The adoption of targeted therapy and immunotherapy has revolutionised the treatment landscape of non-small cell lung cancer. For early staged disease, incorporation of targeted therapy and immunotherapy has recently been demonstrated to reduce recurrence. Development of tar...
Autores principales: | Li, Molly S. C., Mok, Kevin K. S., Mok, Tony S. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477626/ https://www.ncbi.nlm.nih.gov/pubmed/37675321 http://dx.doi.org/10.21037/atm-22-4444 |
Ejemplares similares
-
Non-Small Cell Lung Cancer: The Challenges of the Next Decade
por: Le Chevalier, Thierry
Publicado: (2011) -
How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
por: Remon, Jordi, et al.
Publicado: (2021) -
Confronting the burden of tobacco-related lung cancer in Europe in the next decades
por: ten Haaf, Kevin
Publicado: (2021) -
Immunotherapy for early triple negative breast cancer: research agenda for the next decade
por: Tarantino, Paolo, et al.
Publicado: (2022) -
How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade?
por: Bülow, Roman David, et al.
Publicado: (2021)